Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

680
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
680
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

747
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
747
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

709
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
709
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

415
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
415

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptom burden, lung function, exercise tolerance and inflammation in patients post COVID-19: results from the prospective COVID-19 Chronic Morbidity (CCHROMO) study.

BMC pulmonary medicine·2026
Same author

Establishing a Cone Beam CT-Guided Bronchoscopy Program: A Stepwise Guide for Interventional Pulmonologists.

Diagnostics (Basel, Switzerland)·2026
Same author

Association of German Bronchiectasis Registry participation with disease course.

ERJ open research·2026
Same author

Pre-diagnosed sleep apnoea is linked to severe courses in community-acquired pneumonia.

ERJ open research·2026
Same author

Successful Mediastinal Cryobiopsy Using the Slim UCP190F EBUS Bronchoscope and a 25G Needle: Demonstrating the Efficacy of the Ariza-Pallares Approach.

Respirology case reports·2026
Same author

[Management of patients with chronic obstructive pulmonary disease in routine clinical practice].

Innere Medizin (Heidelberg, Germany)·2026
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

[Community-acquired pneumonia].

Gernot Rohde1

  • 1Pneumologie/Allergologie, Medizinische Klinik 1, Universitätsklinikum Frankfurt - Goethe-Universität, Frankfurt am Main.

Deutsche Medizinische Wochenschrift (1946)
|October 9, 2019
PubMed
Summary
This summary is machine-generated.

New insights into community-acquired pneumonia (CAP) include identifying respiratory viruses as key pathogens. Blood glucose levels improve risk prediction, guiding refined, risk-adapted antibiotic treatments with new options available.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.7K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.4K

Related Experiment Videos

Last Updated: Jan 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.7K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.4K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Medicine

Background:

  • Community-acquired pneumonia (CAP) management is evolving.
  • Understanding of CAP pathogens and treatment strategies is advancing.

Purpose of the Study:

  • To summarize recent developments in CAP understanding.
  • To highlight new pathogens, risk stratification methods, and antibiotic treatments for CAP.

Main Methods:

  • Review of recent literature on community-acquired pneumonia.
  • Analysis of emerging data on pathogens, risk scores, and therapeutic options.

Main Results:

  • Respiratory viruses like influenza and rhinoviruses are recognized as significant CAP pathogens.
  • Blood glucose levels enhance traditional risk stratification scores for CAP patients.
  • Risk-adapted antibiotic strategies are refined, favoring macrolides in specific cases.
  • New antibiotics offer expanded therapeutic choices for CAP.

Conclusions:

  • Advances in understanding CAP pathogens, risk stratification, and antibiotic therapy are improving patient management.
  • Integrated approaches incorporating viral diagnostics and refined risk assessment are crucial.
  • The development of novel antibiotics provides enhanced treatment options for community-acquired pneumonia.